Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat5a
|
ENSMUSG00000004043.8 | signal transducer and activator of transcription 5A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_100874278_100874429 | Stat5a | 4666 | 0.152694 | -0.50 | 4.5e-05 | Click! |
chr11_100874078_100874229 | Stat5a | 4866 | 0.150804 | -0.49 | 6.7e-05 | Click! |
chr11_100861971_100862216 | Stat5a | 1608 | 0.287378 | -0.19 | 1.4e-01 | Click! |
chr11_100859820_100861326 | Stat5a | 88 | 0.956652 | 0.18 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_25077528_25081106 | 4.24 |
Tmem204 |
transmembrane protein 204 |
1093 |
0.35 |
chr7_101377838_101379825 | 3.77 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
462 |
0.71 |
chr11_102217551_102219283 | 3.75 |
Hdac5 |
histone deacetylase 5 |
511 |
0.62 |
chr11_97050817_97052901 | 3.67 |
Gm11574 |
predicted gene 11574 |
427 |
0.42 |
chr4_62699646_62700723 | 3.63 |
Rgs3 |
regulator of G-protein signaling 3 |
504 |
0.76 |
chr17_81737002_81738450 | 3.43 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr2_26583920_26584875 | 3.43 |
Egfl7 |
EGF-like domain 7 |
492 |
0.6 |
chr15_81247657_81248208 | 3.20 |
8430426J06Rik |
RIKEN cDNA 8430426J06 gene |
36 |
0.97 |
chr1_34120973_34122005 | 3.15 |
Dst |
dystonin |
239 |
0.92 |
chr14_36918744_36919600 | 3.13 |
Ccser2 |
coiled-coil serine rich 2 |
161 |
0.97 |
chr14_34587287_34588669 | 3.10 |
Ldb3 |
LIM domain binding 3 |
503 |
0.69 |
chrX_61184931_61185082 | 3.09 |
Cdr1 |
cerebellar degeneration related antigen 1 |
552 |
0.74 |
chr1_134802830_134803774 | 3.02 |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
549 |
0.61 |
chr6_115990945_115992684 | 3.01 |
Plxnd1 |
plexin D1 |
3191 |
0.2 |
chr2_76805230_76805433 | 3.00 |
Ttn |
titin |
21211 |
0.22 |
chr18_11057575_11058184 | 2.97 |
Gata6 |
GATA binding protein 6 |
1168 |
0.53 |
chr8_45660711_45661611 | 2.93 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
832 |
0.66 |
chr1_40465628_40466339 | 2.90 |
Il18r1 |
interleukin 18 receptor 1 |
13 |
0.98 |
chr18_11049995_11051717 | 2.89 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr8_35591141_35592463 | 2.86 |
Gm16793 |
predicted gene, 16793 |
2830 |
0.24 |
chr11_59138017_59138780 | 2.84 |
Obscn |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
772 |
0.52 |
chr14_101842332_101842898 | 2.83 |
Lmo7 |
LIM domain only 7 |
1796 |
0.46 |
chr3_129331827_129332986 | 2.83 |
Enpep |
glutamyl aminopeptidase |
142 |
0.95 |
chrX_61184634_61184785 | 2.82 |
Cdr1 |
cerebellar degeneration related antigen 1 |
849 |
0.57 |
chr8_68120390_68121526 | 2.81 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
355 |
0.92 |
chr2_80037645_80038971 | 2.81 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
721 |
0.79 |
chr11_86586191_86587628 | 2.80 |
Vmp1 |
vacuole membrane protein 1 |
28 |
0.97 |
chr7_17060653_17061482 | 2.76 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
1317 |
0.27 |
chr9_44486015_44488913 | 2.76 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr3_129330284_129331144 | 2.72 |
Enpep |
glutamyl aminopeptidase |
1550 |
0.35 |
chr8_4404476_4405480 | 2.68 |
Gm45118 |
predicted gene 45118 |
2133 |
0.2 |
chr6_115984719_115988278 | 2.63 |
Plxnd1 |
plexin D1 |
8507 |
0.15 |
chr1_51294105_51294669 | 2.62 |
Cavin2 |
caveolae associated 2 |
5261 |
0.21 |
chr19_6933255_6934754 | 2.61 |
Kcnk4 |
potassium channel, subfamily K, member 4 |
450 |
0.59 |
chr3_80080026_80080661 | 2.59 |
Gm19066 |
predicted gene, 19066 |
8816 |
0.2 |
chr3_86040419_86041443 | 2.58 |
Sh3d19 |
SH3 domain protein D19 |
208 |
0.92 |
chr3_19644566_19645227 | 2.57 |
Trim55 |
tripartite motif-containing 55 |
388 |
0.83 |
chr6_91795276_91796520 | 2.54 |
Grip2 |
glutamate receptor interacting protein 2 |
346 |
0.87 |
chr6_48571388_48572885 | 2.53 |
Rarres2 |
retinoic acid receptor responder (tazarotene induced) 2 |
510 |
0.53 |
chr2_60939895_60940920 | 2.51 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22785 |
0.21 |
chr19_5691875_5693863 | 2.45 |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
26 |
0.92 |
chr12_31711352_31711698 | 2.43 |
Gpr22 |
G protein-coupled receptor 22 |
2401 |
0.25 |
chr5_113136296_113136937 | 2.40 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
1370 |
0.27 |
chr8_11314471_11315722 | 2.40 |
Col4a1 |
collagen, type IV, alpha 1 |
2270 |
0.23 |
chr11_103102696_103105788 | 2.40 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr11_75165245_75169157 | 2.38 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr15_8967409_8968940 | 2.37 |
Ranbp3l |
RAN binding protein 3-like |
172 |
0.96 |
chr12_103434225_103434651 | 2.36 |
Ifi27 |
interferon, alpha-inducible protein 27 |
146 |
0.91 |
chr14_63268302_63270010 | 2.35 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr2_32081622_32082932 | 2.35 |
Fam78a |
family with sequence similarity 78, member A |
1506 |
0.26 |
chr15_85672902_85673184 | 2.35 |
Lncppara |
long noncoding RNA near Ppara |
19427 |
0.13 |
chrX_61184439_61184590 | 2.34 |
Cdr1 |
cerebellar degeneration related antigen 1 |
1044 |
0.48 |
chr2_41614891_41615042 | 2.34 |
Lrp1b |
low density lipoprotein-related protein 1B |
174112 |
0.04 |
chr5_115433807_115437237 | 2.34 |
Msi1 |
musashi RNA-binding protein 1 |
24 |
0.93 |
chr7_24462385_24463393 | 2.30 |
Plaur |
plasminogen activator, urokinase receptor |
389 |
0.71 |
chr13_50958059_50958704 | 2.29 |
Gm19009 |
predicted gene, 19009 |
98225 |
0.07 |
chr7_106528440_106529206 | 2.27 |
Gm8995 |
predicted gene 8995 |
17152 |
0.19 |
chr1_184729496_184731200 | 2.26 |
Hlx |
H2.0-like homeobox |
1250 |
0.37 |
chr10_30838746_30839745 | 2.26 |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
2770 |
0.24 |
chr6_124512631_124513557 | 2.22 |
C1ra |
complement component 1, r subcomponent A |
689 |
0.5 |
chr6_3398194_3398580 | 2.22 |
Samd9l |
sterile alpha motif domain containing 9-like |
1185 |
0.44 |
chr2_152931122_152933148 | 2.22 |
Foxs1 |
forkhead box S1 |
1073 |
0.38 |
chr10_81424113_81425703 | 2.20 |
Nfic |
nuclear factor I/C |
2206 |
0.11 |
chr14_63247276_63249044 | 2.18 |
Gata4 |
GATA binding protein 4 |
2889 |
0.24 |
chr16_35157395_35159144 | 2.18 |
Adcy5 |
adenylate cyclase 5 |
3392 |
0.29 |
chr13_113224004_113224583 | 2.17 |
Gzmk |
granzyme K |
1615 |
0.34 |
chr15_25941347_25942080 | 2.17 |
Retreg1 |
reticulophagy regulator 1 |
826 |
0.63 |
chr17_28007198_28009699 | 2.17 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr3_66292264_66292972 | 2.14 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
4130 |
0.27 |
chr3_20153383_20154068 | 2.14 |
Gyg |
glycogenin |
1344 |
0.46 |
chr5_125056018_125058841 | 2.12 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr15_66560466_66561298 | 2.10 |
Tmem71 |
transmembrane protein 71 |
221 |
0.94 |
chr7_106214634_106215341 | 2.09 |
Gvin1 |
GTPase, very large interferon inducible 1 |
323 |
0.89 |
chr3_102086617_102087454 | 2.09 |
Casq2 |
calsequestrin 2 |
396 |
0.81 |
chr7_105953249_105953965 | 2.09 |
Gm4070 |
predicted gene 4070 |
333 |
0.86 |
chrX_73483606_73484999 | 2.09 |
Bgn |
biglycan |
663 |
0.59 |
chrX_157700177_157700800 | 2.08 |
Smpx |
small muscle protein, X-linked |
1228 |
0.39 |
chr14_31209518_31210345 | 2.08 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
1599 |
0.22 |
chr16_55820192_55820446 | 2.08 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1804 |
0.33 |
chr14_54991806_54993467 | 2.07 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1055 |
0.25 |
chr2_27246009_27247328 | 2.07 |
Sardh |
sarcosine dehydrogenase |
180 |
0.94 |
chr2_114051146_114052179 | 2.06 |
Actc1 |
actin, alpha, cardiac muscle 1 |
1225 |
0.4 |
chr1_75217955_75219308 | 2.05 |
Tuba4a |
tubulin, alpha 4A |
7 |
0.92 |
chr10_115817324_115818606 | 2.04 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr9_44069466_44069831 | 2.03 |
Usp2 |
ubiquitin specific peptidase 2 |
205 |
0.83 |
chr7_141463368_141466319 | 2.03 |
Gm10575 |
predicted gene 10575 |
188 |
0.53 |
chr16_21815032_21815191 | 2.01 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
10831 |
0.11 |
chr15_85653123_85654040 | 2.00 |
Lncppara |
long noncoding RNA near Ppara |
35 |
0.97 |
chr7_3290557_3291613 | 1.99 |
Myadm |
myeloid-associated differentiation marker |
405 |
0.65 |
chr3_57293752_57294965 | 1.99 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
194 |
0.95 |
chr1_112456627_112457016 | 1.98 |
Gm22331 |
predicted gene, 22331 |
11090 |
0.28 |
chr11_48869797_48870455 | 1.97 |
Irgm1 |
immunity-related GTPase family M member 1 |
1248 |
0.29 |
chr14_34375555_34377243 | 1.97 |
Mmrn2 |
multimerin 2 |
678 |
0.52 |
chr13_5714127_5714791 | 1.97 |
Gm35330 |
predicted gene, 35330 |
9983 |
0.27 |
chr18_61659524_61661310 | 1.96 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
5073 |
0.12 |
chr5_32745567_32746421 | 1.96 |
Pisd |
phosphatidylserine decarboxylase |
318 |
0.82 |
chr14_123201613_123202658 | 1.96 |
AA536875 |
expressed sequence AA536875 |
32841 |
0.19 |
chr3_79885722_79887545 | 1.95 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr19_29924851_29925655 | 1.95 |
Il33 |
interleukin 33 |
121 |
0.97 |
chr13_6646301_6646452 | 1.94 |
Pfkp |
phosphofructokinase, platelet |
2349 |
0.29 |
chr6_145933944_145934978 | 1.92 |
Sspn |
sarcospan |
339 |
0.86 |
chr7_3289024_3290449 | 1.92 |
Prkcg |
protein kinase C, gamma |
557 |
0.39 |
chr17_71019478_71020561 | 1.91 |
Myom1 |
myomesin 1 |
428 |
0.76 |
chr5_65955085_65956246 | 1.91 |
4930480C01Rik |
RIKEN cDNA 4930480C01 gene |
4360 |
0.13 |
chr10_51405160_51405552 | 1.91 |
Gm46189 |
predicted gene, 46189 |
50624 |
0.11 |
chr10_58394296_58394848 | 1.90 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
184 |
0.95 |
chr5_32137024_32137228 | 1.89 |
Fosl2 |
fos-like antigen 2 |
953 |
0.5 |
chr18_11055272_11055490 | 1.88 |
Gata6 |
GATA binding protein 6 |
343 |
0.89 |
chr14_66279066_66281333 | 1.88 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr17_72921491_72924008 | 1.88 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr8_88635072_88636330 | 1.87 |
Snx20 |
sorting nexin 20 |
400 |
0.84 |
chr10_53339922_53340236 | 1.87 |
Pln |
phospholamban |
2374 |
0.19 |
chr16_77503379_77503945 | 1.87 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
3278 |
0.16 |
chr2_84647866_84648354 | 1.87 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
427 |
0.69 |
chr4_105108487_105108685 | 1.86 |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
1304 |
0.56 |
chr2_32646588_32647989 | 1.86 |
Eng |
endoglin |
295 |
0.76 |
chr1_135836492_135836762 | 1.84 |
Tnnt2 |
troponin T2, cardiac |
214 |
0.9 |
chr18_65024467_65024889 | 1.84 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
954 |
0.61 |
chr1_66896075_66896827 | 1.83 |
Gm25832 |
predicted gene, 25832 |
29654 |
0.09 |
chr13_12105059_12105454 | 1.83 |
Ryr2 |
ryanodine receptor 2, cardiac |
1203 |
0.48 |
chr4_82502069_82502416 | 1.82 |
Nfib |
nuclear factor I/B |
2926 |
0.27 |
chr14_61139006_61139387 | 1.82 |
Sacs |
sacsin |
705 |
0.73 |
chr2_124612015_124613212 | 1.82 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
2012 |
0.47 |
chr1_153752765_153752990 | 1.82 |
Rnasel |
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
25 |
0.95 |
chr9_20868528_20869547 | 1.82 |
Shfl |
shiftless antiviral inhibitor of ribosomal frameshifting |
240 |
0.82 |
chr14_70625458_70627688 | 1.81 |
Dmtn |
dematin actin binding protein |
418 |
0.75 |
chr18_11056331_11056626 | 1.81 |
Gata6 |
GATA binding protein 6 |
1440 |
0.45 |
chr4_57914999_57916744 | 1.80 |
D630039A03Rik |
RIKEN cDNA D630039A03 gene |
426 |
0.84 |
chr19_58413288_58413588 | 1.79 |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
41028 |
0.17 |
chr10_22818712_22820254 | 1.79 |
Tcf21 |
transcription factor 21 |
676 |
0.65 |
chr1_33883300_33883842 | 1.79 |
Bend6 |
BEN domain containing 6 |
81 |
0.96 |
chr1_164455819_164456603 | 1.78 |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
1811 |
0.27 |
chr9_105520039_105521535 | 1.78 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr15_5107710_5108629 | 1.77 |
Card6 |
caspase recruitment domain family, member 6 |
315 |
0.81 |
chr2_180388160_180389480 | 1.77 |
Mir1a-1 |
microRNA 1a-1 |
228 |
0.89 |
chr9_53609339_53609759 | 1.77 |
Acat1 |
acetyl-Coenzyme A acetyltransferase 1 |
781 |
0.57 |
chr11_100967422_100967790 | 1.77 |
Cavin1 |
caveolae associated 1 |
2945 |
0.18 |
chr3_79180505_79180656 | 1.76 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
760 |
0.66 |
chr9_101198368_101199080 | 1.76 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
127 |
0.94 |
chr2_77168707_77169120 | 1.75 |
Ccdc141 |
coiled-coil domain containing 141 |
1663 |
0.41 |
chr2_173273081_173273998 | 1.75 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
2650 |
0.25 |
chr6_108660446_108661582 | 1.75 |
0610040F04Rik |
RIKEN cDNA 0610040F04 gene |
80 |
0.58 |
chr16_23610624_23611298 | 1.75 |
Rtp4 |
receptor transporter protein 4 |
1036 |
0.59 |
chr7_112956295_112957421 | 1.74 |
Rassf10 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10 |
2896 |
0.26 |
chr16_45096956_45097933 | 1.74 |
Ccdc80 |
coiled-coil domain containing 80 |
3391 |
0.27 |
chr4_102256022_102256825 | 1.74 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1193 |
0.63 |
chr16_34922552_34923302 | 1.74 |
Mylk |
myosin, light polypeptide kinase |
7415 |
0.19 |
chr15_76306649_76307769 | 1.73 |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
36 |
0.93 |
chr5_17848825_17849185 | 1.73 |
Cd36 |
CD36 molecule |
724 |
0.8 |
chr15_98601965_98602724 | 1.72 |
Adcy6 |
adenylate cyclase 6 |
2387 |
0.14 |
chr17_69105006_69106089 | 1.72 |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
21453 |
0.26 |
chr15_85654048_85654569 | 1.72 |
Lncppara |
long noncoding RNA near Ppara |
692 |
0.63 |
chr12_85686314_85687645 | 1.71 |
Batf |
basic leucine zipper transcription factor, ATF-like |
310 |
0.85 |
chr4_40850475_40851213 | 1.71 |
Gm25931 |
predicted gene, 25931 |
442 |
0.43 |
chr10_12812573_12812894 | 1.71 |
Utrn |
utrophin |
816 |
0.64 |
chr18_35840074_35842769 | 1.71 |
Gm29417 |
predicted gene 29417 |
10328 |
0.1 |
chr3_97076352_97076977 | 1.70 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16121 |
0.15 |
chr11_68555954_68556965 | 1.70 |
Mfsd6l |
major facilitator superfamily domain containing 6-like |
273 |
0.89 |
chr2_180332745_180333375 | 1.70 |
Gata5os |
GATA binding protein 5, opposite strand |
203 |
0.89 |
chr13_32338810_32339340 | 1.68 |
A730091E23Rik |
RIKEN cDNA A730091E23 gene |
256 |
0.58 |
chr4_152447653_152448768 | 1.68 |
Kcnab2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
531 |
0.76 |
chr10_127749619_127751660 | 1.68 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr8_80482917_80483286 | 1.68 |
Gypa |
glycophorin A |
10680 |
0.24 |
chr11_118429199_118429661 | 1.68 |
C1qtnf1 |
C1q and tumor necrosis factor related protein 1 |
931 |
0.46 |
chr14_25765564_25767000 | 1.67 |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
2757 |
0.22 |
chr10_53341465_53341738 | 1.67 |
Gm47644 |
predicted gene, 47644 |
2633 |
0.18 |
chr8_35378537_35379185 | 1.67 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
2201 |
0.24 |
chr9_107298004_107299417 | 1.66 |
Cish |
cytokine inducible SH2-containing protein |
445 |
0.63 |
chr11_5505783_5506171 | 1.66 |
Gm11963 |
predicted gene 11963 |
7137 |
0.14 |
chr9_116872888_116873412 | 1.66 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
50331 |
0.18 |
chr13_46217950_46218678 | 1.66 |
Gm10113 |
predicted gene 10113 |
27268 |
0.21 |
chr6_48684916_48685953 | 1.66 |
Gimap4 |
GTPase, IMAP family member 4 |
852 |
0.34 |
chr11_121434299_121435595 | 1.66 |
Fn3k |
fructosamine 3 kinase |
20 |
0.96 |
chr4_114821344_114822510 | 1.65 |
Gm12830 |
predicted gene 12830 |
205 |
0.94 |
chr11_100967960_100968469 | 1.65 |
Cavin1 |
caveolae associated 1 |
2337 |
0.21 |
chr14_63244119_63245953 | 1.65 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr18_39483580_39484106 | 1.65 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
3389 |
0.32 |
chr11_21368409_21368742 | 1.65 |
Gm12043 |
predicted gene 12043 |
1825 |
0.24 |
chr5_114147552_114147966 | 1.64 |
Acacb |
acetyl-Coenzyme A carboxylase beta |
1224 |
0.34 |
chr6_129450832_129451818 | 1.64 |
Clec1a |
C-type lectin domain family 1, member a |
510 |
0.65 |
chr17_26840029_26840609 | 1.64 |
Nkx2-5 |
NK2 homeobox 5 |
1246 |
0.32 |
chr11_65268412_65269105 | 1.64 |
Myocd |
myocardin |
1096 |
0.55 |
chr13_109229388_109230388 | 1.64 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
30766 |
0.25 |
chr1_135839024_135839175 | 1.64 |
Tnnt2 |
troponin T2, cardiac |
1600 |
0.28 |
chr3_65494285_65495219 | 1.63 |
Gm34780 |
predicted gene, 34780 |
283 |
0.87 |
chr10_22815271_22815569 | 1.63 |
Gm10824 |
predicted gene 10824 |
329 |
0.86 |
chr16_74739483_74739671 | 1.63 |
Gm26307 |
predicted gene, 26307 |
131820 |
0.05 |
chr11_78983615_78983970 | 1.63 |
Lgals9 |
lectin, galactose binding, soluble 9 |
1039 |
0.52 |
chr8_104101710_104103631 | 1.63 |
Cdh5 |
cadherin 5 |
1045 |
0.43 |
chr6_149567650_149567820 | 1.62 |
Gm21814 |
predicted gene, 21814 |
1603 |
0.31 |
chr8_114351912_114352398 | 1.62 |
4933408N05Rik |
RIKEN cDNA 4933408N05 gene |
676 |
0.74 |
chr11_61142503_61142888 | 1.61 |
Tnfrsf13b |
tumor necrosis factor receptor superfamily, member 13b |
30 |
0.97 |
chr11_6561209_6561949 | 1.61 |
Ccm2 |
cerebral cavernous malformation 2 |
349 |
0.72 |
chr13_46926552_46927282 | 1.61 |
Kif13a |
kinesin family member 13A |
2800 |
0.19 |
chr3_19646421_19646748 | 1.61 |
Trim55 |
tripartite motif-containing 55 |
2076 |
0.26 |
chr17_12766020_12767485 | 1.61 |
Igf2r |
insulin-like growth factor 2 receptor |
2912 |
0.17 |
chr5_12507320_12507854 | 1.60 |
Sema3d |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
22632 |
0.19 |
chr8_126056070_126056237 | 1.60 |
Gm45876 |
predicted gene 45876 |
4371 |
0.23 |
chr4_132397551_132398511 | 1.60 |
Phactr4 |
phosphatase and actin regulator 4 |
168 |
0.89 |
chr6_134208037_134208551 | 1.60 |
Etv6 |
ets variant 6 |
25306 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.4 | 11.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.0 | 6.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.9 | 5.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.8 | 5.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.6 | 4.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.4 | 4.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.3 | 3.9 | GO:0007525 | somatic muscle development(GO:0007525) |
1.3 | 5.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.2 | 2.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.2 | 2.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.1 | 5.4 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.0 | 6.1 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
1.0 | 4.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.0 | 3.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.0 | 2.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.0 | 2.9 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.9 | 5.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.9 | 0.9 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.9 | 3.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.9 | 1.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.9 | 3.4 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.9 | 2.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 4.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.8 | 1.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.8 | 7.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.8 | 2.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.8 | 3.3 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.8 | 1.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.8 | 2.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.8 | 0.8 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.8 | 2.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.8 | 3.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 2.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 3.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 2.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.7 | 3.0 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.7 | 1.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.7 | 2.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.7 | 2.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 2.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 3.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 4.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.7 | 3.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 1.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.7 | 4.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.7 | 1.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 2.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.7 | 2.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 1.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.7 | 2.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 2.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 0.6 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.6 | 6.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 1.9 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.6 | 2.5 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.6 | 1.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 1.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 2.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 1.8 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.6 | 5.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.6 | 2.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 0.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 1.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 0.6 | GO:1900825 | septum primum development(GO:0003284) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.5 | 2.7 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.5 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 1.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 1.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.5 | 0.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.5 | 1.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 1.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 1.1 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.5 | 5.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 1.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.5 | 2.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.5 | 1.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 1.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 2.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 2.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 1.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 3.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 1.9 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 1.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.5 | 1.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.5 | 1.4 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 1.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 2.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.5 | 1.4 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.5 | 1.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.5 | 1.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.5 | 0.9 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.5 | 1.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 1.9 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.5 | 1.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.5 | 1.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 1.8 | GO:0009838 | abscission(GO:0009838) |
0.5 | 1.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.5 | 1.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.5 | 1.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.5 | 2.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.5 | 0.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 0.9 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 2.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.4 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 0.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 2.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 1.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.4 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 0.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 1.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 1.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 2.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 0.9 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 1.7 | GO:0035482 | gastric motility(GO:0035482) |
0.4 | 1.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 0.8 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 0.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 2.0 | GO:0042701 | progesterone secretion(GO:0042701) |
0.4 | 1.6 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 0.8 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 0.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 1.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 0.8 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.4 | 1.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.4 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 2.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.4 | 0.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 1.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 1.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.4 | 1.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.4 | 3.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 1.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 10.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.4 | 1.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.4 | 2.9 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.4 | 1.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 1.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 3.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 0.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 0.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 1.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 0.4 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 1.4 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.3 | 1.4 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 5.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.0 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 0.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 4.8 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 1.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 1.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 1.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.3 | 1.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 1.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 1.0 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 1.3 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.3 | 1.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 5.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 2.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 1.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 1.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 1.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 2.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.3 | 1.0 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.3 | 4.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 1.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 1.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 2.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 1.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 3.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.9 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.3 | 1.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 0.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 0.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 1.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 0.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 2.4 | GO:0097531 | mast cell migration(GO:0097531) |
0.3 | 1.8 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 6.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 2.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.3 | 1.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 0.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 2.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 3.0 | GO:0043217 | myelin maintenance(GO:0043217) |
0.3 | 1.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.9 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 2.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.3 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.3 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 1.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 0.3 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 3.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 1.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 0.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 1.4 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 0.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.3 | 0.6 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 0.5 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.3 | 3.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 1.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.3 | 0.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 3.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 2.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 0.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 0.5 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.3 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.3 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 0.3 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.8 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 0.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 2.3 | GO:0060547 | regulation of necroptotic process(GO:0060544) negative regulation of necrotic cell death(GO:0060547) |
0.3 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.5 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.3 | 2.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 2.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.8 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.3 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 0.5 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.3 | 1.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 1.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 0.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 4.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 2.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 1.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 1.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 1.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 1.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.7 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 1.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 1.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.5 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.2 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.2 | 5.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.7 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 1.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.7 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.7 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 1.8 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 2.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 1.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.2 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 1.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.9 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.4 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.7 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.7 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 1.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 2.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.2 | 0.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.6 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 4.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.4 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 0.4 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.2 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.2 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.2 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 1.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.2 | 1.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 1.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.8 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 0.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.8 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.2 | 0.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 3.5 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.6 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 2.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 1.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 1.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.4 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.2 | 1.0 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 1.7 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.2 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.2 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.4 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 1.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.7 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 0.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.4 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.7 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 2.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.7 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.9 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.2 | 0.4 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 5.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 3.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 1.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 1.3 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 1.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.7 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 0.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 4.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.4 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.2 | 0.4 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.9 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 0.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.7 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 1.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.2 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.2 | 0.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.7 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 1.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 3.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 1.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 0.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.2 | 0.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 1.4 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 2.7 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.2 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.3 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 2.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 3.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.5 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.2 | 0.6 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 1.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.9 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.7 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 1.0 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 2.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.6 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.1 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.6 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 3.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.3 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 1.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.8 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.7 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.1 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.8 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 1.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 12.3 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 1.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.3 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.1 | 0.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 1.1 | GO:0075733 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.4 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 3.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 3.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.4 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 1.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.6 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.6 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.1 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 1.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.6 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.7 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.1 | 0.9 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 1.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.3 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.1 | 0.4 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.5 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.1 | GO:0014897 | striated muscle hypertrophy(GO:0014897) |
0.1 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.2 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 1.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 2.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.3 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.3 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 1.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.1 | 1.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.7 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 1.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:0018377 | N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
0.1 | 0.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 2.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.6 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 2.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.2 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.2 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.1 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0046113 | purine nucleobase catabolic process(GO:0006145) nucleobase catabolic process(GO:0046113) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.1 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.5 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.4 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.4 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0045472 | response to ether(GO:0045472) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.1 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.2 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.2 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.1 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.1 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 1.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 1.9 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.2 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 1.5 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.9 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 2.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.4 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.4 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.2 | GO:1900060 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.8 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 2.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.6 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.5 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.8 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.1 | 2.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.1 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 3.9 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetylcholine biosynthetic process(GO:0008292) acetate ester metabolic process(GO:1900619) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.3 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.8 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.1 | 1.1 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 1.0 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.2 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
0.1 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.1 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.3 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.4 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.9 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 1.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.5 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0051299 | mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 1.1 | GO:2000816 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.0 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.0 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.0 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.3 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.3 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 1.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.6 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 1.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.2 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 1.5 | GO:0043039 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.0 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.0 | 0.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.7 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 0.1 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0060214 | endocardium formation(GO:0060214) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 3.9 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.8 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.2 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.3 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
0.0 | 0.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.1 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.0 | 0.7 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.7 | GO:0061572 | actin filament bundle organization(GO:0061572) |
0.0 | 0.0 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 2.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.4 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.0 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.4 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.1 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.0 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.3 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0018214 | protein carboxylation(GO:0018214) |
0.0 | 0.3 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.0 | GO:0090493 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 1.2 | GO:0098542 | defense response to other organism(GO:0098542) |
0.0 | 0.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.0 | 0.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.2 | 7.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.0 | 5.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 2.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 2.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 6.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.7 | 2.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.7 | 2.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 2.7 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 2.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.7 | 2.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 2.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 5.2 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 5.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 3.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 3.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 1.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 2.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.6 | 1.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 6.3 | GO:0031430 | M band(GO:0031430) |
0.5 | 1.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 7.6 | GO:0043034 | costamere(GO:0043034) |
0.5 | 2.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 2.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 2.6 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 1.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 3.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 1.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 1.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 2.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 5.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 3.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 1.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 16.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 33.4 | GO:0030016 | myofibril(GO:0030016) |
0.3 | 5.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 2.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 1.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 2.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 11.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 2.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 4.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 4.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 6.1 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 4.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 0.3 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.3 | 1.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 0.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 0.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.2 | 1.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 1.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 8.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.9 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 11.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.8 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 0.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 2.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 1.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 2.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.0 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 4.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 0.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 3.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.5 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.4 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 8.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 2.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.7 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.5 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 1.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 2.1 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 6.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 4.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 5.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 3.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 2.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 1.1 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 2.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.0 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 2.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.7 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.2 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 3.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 7.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 17.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 1.2 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 6.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 1.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 2.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 8.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 1.8 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 2.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 3.3 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 5.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.2 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.8 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 2.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.6 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 7.7 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 4.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 4.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 1.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 1.9 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 1.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 1.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 3.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 6.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 2.0 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 2.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 49.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 30.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 7.0 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.8 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.0 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 1.4 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 7.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.6 | GO:0031433 | telethonin binding(GO:0031433) |
1.5 | 4.6 | GO:0070538 | oleic acid binding(GO:0070538) |
1.4 | 6.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 3.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 5.3 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 3.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 1.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 4.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 2.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 6.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 4.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.8 | 1.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 2.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 4.1 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 2.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.7 | 5.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 2.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 1.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 5.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 1.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 5.1 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 3.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 2.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 11.3 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 2.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 6.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 1.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 1.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 2.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 5.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 1.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 1.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 1.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 3.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 2.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 2.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 0.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 3.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 1.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 1.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.4 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 2.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 1.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 1.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 7.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 2.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 3.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 1.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 2.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 1.1 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 0.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 1.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.3 | 1.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 3.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 6.8 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 2.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 3.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 1.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 1.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 1.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 2.2 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 3.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 3.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 0.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 2.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 3.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 1.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 2.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 2.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 2.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.4 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 4.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 5.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 1.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 0.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 3.6 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 3.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.3 | 1.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 2.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 1.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 2.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 2.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 2.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 1.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.9 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 1.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.9 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.9 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.7 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 2.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 2.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 2.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.2 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.2 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 2.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 1.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 1.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 11.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.4 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 1.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 1.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 1.2 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 2.5 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 3.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 1.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 2.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 1.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 4.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.6 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.2 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.7 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.6 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.1 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 1.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.9 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 1.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 2.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 8.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 2.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 2.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.7 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 1.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 3.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 3.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 3.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 2.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 2.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.5 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 1.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 2.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.2 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.2 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 2.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 1.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 8.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 2.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.7 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.6 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 5.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 35.4 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.2 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 24.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 1.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 2.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.7 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.7 | GO:0018503 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 1.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 2.4 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 2.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 6.4 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 3.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 2.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 7.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 2.6 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 3.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.0 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.5 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 2.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 2.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.5 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 2.4 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 4.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.6 | GO:0034793 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 16.9 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 1.2 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 3.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 1.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.4 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 2.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 5.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 3.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 2.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 1.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 1.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.0 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 1.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 7.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 1.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.4 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.4 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0016726 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.8 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 1.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 1.1 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 1.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 6.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.0 | GO:0070696 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.0 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.0 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 2.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.0 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0000182 | rDNA binding(GO:0000182) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 3.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 5.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 15.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 2.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 6.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 3.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 3.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 3.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 6.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 4.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 3.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 2.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 5.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 8.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 10.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 3.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 8.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 1.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 5.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 6.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 6.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 4.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 6.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 5.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 8.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 3.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 1.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 5.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 5.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 4.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 4.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 3.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 8.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 3.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 3.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 5.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 6.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 4.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 11.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 5.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID E2F PATHWAY | E2F transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 20.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 11.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 3.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 4.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 5.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 2.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 1.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.4 | 6.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 5.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 3.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 14.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 1.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 10.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 6.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 6.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 2.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 3.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 7.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 2.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 1.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 2.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 1.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 1.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 3.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 3.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 25.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 3.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 1.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 17.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 5.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 1.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 6.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 2.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 2.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 1.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 2.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 6.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 1.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 4.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 8.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 3.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 2.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 4.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 2.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 3.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 3.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 1.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 3.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.7 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 1.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 3.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 2.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 1.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 3.4 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |